Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

TIMBER PHARMACEUTICALS, INC.

(TMBR)
 SummaryQuotesChartsNewsCalendarCompanyFinancials 
Quotes 5-day view   Delayed Quote. Delayed Nyse
11/29/2021 11/30/2021 12/01/2021 12/02/2021 12/03/2021 Date
0.4653(c) 0.4601(c) 0.4176(c) 0.3985(c) 0.375(c) Last
2 121 924 3 385 795 2 621 527 2 762 112 2 523 348 Volume
-0.47% -1.12% -9.24% -4.57% -5.90% Change
More quotes
Estimated financial data (e) (USD)
Sales 2019 0,32 M - -
Net income 2019 -3,64 M - -
Net cash position 2019 0,06 M - -
P/E ratio 2019 -
Yield 2019 -
Sales 2020 0,45 M - -
Net income 2020 -15,1 M - -
Net cash position 2020 9,51 M - -
P/E ratio 2020 -0,76x
Yield 2020 -
Capitalization 23,9 M 23,9 M -
EV / Sales 2019 -
EV / Sales 2020 -1,26x
Nbr of Employees 6
Free-Float 94,8%
More Financials
Company
Timber Pharmaceuticals, Inc. (Timber) is a clinical-stage biopharmaceutical company. The Company is focused on development of treatments for orphan dermatologic diseases. It also includes developing non-systemic treatments for dermatologic diseases including congenital ichthyosis, facial angiofibromas(FAs) in tuberous sclerosis complex (TSC), and scleroderma. The Company's pipeline programs include TMB-001, TMB-002... 
More about the company
All news about TIMBER PHARMACEUTICALS, INC.
11/22TIMBER PHARMACEUTICALS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits..
AQ
11/17Timber Pharmaceuticals to Host Conference Call Discussing Positive Topline Results from..
GL
11/15TIMBER PHARMACEUTICALS : Provides Business Update and Announces Third Quarter 2021 Financi..
PU
11/15Earnings Flash (TMBR) TIMBER PHARMACEUTICALS Reports Q3 Revenue $267,000
MT
11/15Timber Pharmaceuticals Provides Business Update and Announces Third Quarter 2021 Financ..
AQ
11/15Timber Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Mo..
CI
11/09Timber Pharmaceuticals Announces Closing ofáExercise of Underwriter's Option to Purchas..
AQ
11/05Timber Pharmaceuticals Closes Public Offering -- Shares Gain After-Hours
MT
11/05Timber Pharmaceuticals Announces Closing of $15 Million Public Offering
GL
11/04Timber Pharmaceuticals Announces Proposed Public Offering - Form 8-K
PU
11/04TIMBER PHARMACEUTICALS, INC. : Entry into a Material Definitive Agreement, Other Events, F..
AQ
11/03Health Care Stocks Closing Near Intra-Day Highs
MT
11/03Health Care Stocks Slipping This Afternoon
MT
11/03Wall Street Set to Open Largely Flat Ahead of Fed Decision
MT
11/03Timber Pharmaceuticals to Seek Acquisitions
CI
More news
News in other languages on TIMBER PHARMACEUTICALS, INC.
11/15Earnings Flash (TMBR) TIMBER PHARMACEUTICALS annonce un revenu de 267 000 $ pour le tro..
11/05Timber Pharmaceuticals clôture son appel public à l'épargne - Les actions progressent a..
11/03Les actions du secteur de la santé clôturent près de leur sommet du jour
11/03Les actions du secteur de la santé en baisse cet après-midi
11/03Timber Pharmaceuticals propose une offre d'actions ; les actions chutent avant l'ouvert..
More news
Chart TIMBER PHARMACEUTICALS, INC.
Duration : Period :
Timber Pharmaceuticals, Inc. Technical Analysis Chart | TMBR | US8870801094 | MarketScreener
Technical analysis trends TIMBER PHARMACEUTICALS, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Managers and Directors
John Koconis Chairman & Chief Executive Officer
Joseph Lucchese Chief Financial Officer & Executive Vice President
Alan Mendelsohn Chief Medical Officer & Executive Vice President
Zachary Rome COO, Secretary, Director & Executive VP
Edward J. Sitar Lead Independent Director
Sector and Competitors
1st jan.Capi. (M$)
TIMBER PHARMACEUTICALS, INC.-49.53%24
MODERNA, INC.193.60%124 359
LONZA GROUP AG25.98%58 058
IQVIA HOLDINGS INC.46.05%49 991
SEAGEN INC.-13.93%27 564
CELLTRION, INC.-41.36%24 298